title: Type III cryoglobulinemia complicated by renal cortical necrosis.
abstract: Renal involvement is rare in patients with type III cryoglobulinemia. We report a case of renal cortical necrosis in a patient with type III cryoglobulinemia. Renal function improved partially after treatment with plasma exchange, steroids, and cyclophosphamide. Renal magnetic resonance imaging was a valuable tool in the evaluation of the extent of renal cortical necrosis and improvement in renal vascularization after treatment.
authors.affiliation: Department of Nephrology, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Thaunat
authors.forename: Laurent
authors.initials: L
authors.lastname: Aaron
authors.forename: Cédric
authors.initials: C
authors.lastname: Desbene
authors.forename: Laure-Hélène
authors.initials: LH
authors.lastname: Noël
authors.forename: Alexandre
authors.initials: A
authors.lastname: Karras
authors.forename: Philippe
authors.initials: P
authors.lastname: Lesavre
authors.forename: Marie-Alexandra
authors.initials: MA
authors.lastname: Alyanakian
authors.forename: Fadi
authors.initials: F
authors.lastname: Fakhouri
mesh_terms: D001172:Arthritis, Rheumatoid / Q000150:complications; D001706:Biopsy; D003131:Combined Modality Therapy; D003449:Cryoglobulinemia / Q000145:classification / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006111:Graves Disease / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007673:Kidney Cortex Necrosis / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D010956:Plasmapheresis; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D014581:Urticaria / Q000150:complications
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone